Literature DB >> 10346753

Better blood transfusion.

D Provan.   

Abstract

Mesh：

Year:  1999        PMID： 10346753      PMCID： PMC1115826          DOI： 10.1136/bmj.318.7196.1435

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Royal College of Physicians of Edinburgh. Autologous transfusion, 3 years on: what is new? What has happened?

Authors:  J P Allain; R L Akehurst; J M Hunter
Journal:  Transfusion       Date:  1999-08       Impact factor: 3.157

Review 2.  Transfusion-associated graft-versus-host disease.

Authors:  K C Anderson; H J Weinstein
Journal:  N Engl J Med       Date:  1990-08-02       Impact factor: 91.245

3.  Blood transfusion risk: protecting against the unknown.

Authors:  J Barbara; P Flanagan
Journal:  BMJ       Date:  1998-03-07

Review 4.  Transfusion medicine. Accept no substitute.

Authors:  F K Widmann
Journal:  Lancet       Date:  1997 Dec 20-27       Impact factor: 79.321

5.  Guidelines for autologous transfusion. II. Perioperative haemodilution and cell salvage. British Committee for Standards in Haematology Blood Transfusion Task Force. Autologous Transfusion Working Party.

Authors:  J A Napier; M Bruce; J Chapman; J K Duguid; P R Kelsey; S M Knowles; M F Murphy; L M Williamson; J K Wood; D Lee; M Contreras; N Cross; M J Desmond; J Gillon; A Lardy; F G Williams
Journal:  Br J Anaesth       Date:  1997-06       Impact factor: 9.166

6.  A SHOT in the arm for safer blood transfusion.

Authors:  L M Williamson; J Heptonstall; K Soldan
Journal:  BMJ       Date:  1996-11-16

7.  Post-transfusion purpura.

Authors:  C Mueller-Eckhardt
Journal:  Br J Haematol       Date:  1986-11       Impact factor: 6.998

8.  The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery.

Authors:  S A Gould; E E Moore; D B Hoyt; J M Burch; J B Haenel; J Garcia; R DeWoskin; G S Moss
Journal:  J Am Coll Surg       Date:  1998-08       Impact factor: 6.113

9.  Immunomodulatory activity of different blood products on the mitogen-induced human lymphocyte transformation.

Authors:  W Sibrowski; W Wegner; P Kühnl
Journal:  Transfus Med       Date:  1992-09       Impact factor: 2.019
  9 in total
  6 in total

1.  Serious hazards of transfusion (SHOT) initiative. Conclusion was not supported by data presented.

Authors:  P Nederlof
Journal:  BMJ       Date:  2000-04-15

2.  Autologous versus allogeneic transfusion in aortic surgery: a multicenter randomized clinical trial.

Authors:  Julian C L Wong; Francesco Torella; Sarah L Haynes; Kirsteen Dalrymple; Andrew J Mortimer; Charles N McCollum
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

3.  Transfusion requirements and outcomes in patients undergoing abdominal aortic surgery using intra-operative cell salvage.

Authors:  C F Healy; M Doyle; B Egan; B Hendrick; M K O'Malley; M K O'Donohoe
Journal:  Ir J Med Sci       Date:  2007-03       Impact factor: 1.568

4.  Tattooing and transfusion-transmitted diseases in Brazil: a hospital-based cross-sectional matched study.

Authors:  Sérgio A de Nishioka; T W Gyorkos; L Joseph; J P Collet; J D MacLean
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

5.  Factors that motivate and hinder blood donation in Greece.

Authors:  O Marantidou; L Loukopoulou; E Zervou; G Martinis; A Egglezou; P Fountouli; P Dimoxenous; M Parara; M Gavalaki; A Maniatis
Journal:  Transfus Med       Date:  2007-12       Impact factor: 2.019

Review 6.  Investigation on artificial blood or substitute blood replace the natural blood.

Authors:  Sh Keyhanian; M Ebrahimifard; M Zandi
Journal:  Iran J Ped Hematol Oncol       Date:  2014-04-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.